The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.
 
Albert Abad
No Relationships to Disclose
 
Jose M Vieitez
No Relationships to Disclose
 
Vicente Alonso
No Relationships to Disclose
 
Pilar Garcia Alfonso
No Relationships to Disclose
 
Jose Luis Manzano
No Relationships to Disclose
 
Bartomeu Massuti
No Relationships to Disclose
 
Manuel Benavides
Consulting or Advisory Role - Roche
 
Alfredo Carrato
No Relationships to Disclose
 
Jordi Remon
No Relationships to Disclose
 
Javier Gallego Plazas
No Relationships to Disclose
 
Veronica Conde
No Relationships to Disclose
 
Cristina Gravalos Castro
No Relationships to Disclose
 
Manuel Valladares
No Relationships to Disclose
 
Mariano Provencio
No Relationships to Disclose
 
Ramon Salazar
Consulting or Advisory Role - Amgen; Merck Serono
Speakers' Bureau - Amgen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Merck; Novartis; Roche
 
Manuel Gallen
No Relationships to Disclose
 
Fernando Rivera
No Relationships to Disclose
 
Javier Sastre
No Relationships to Disclose
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi
 
Eva Martinez-Balibrea
No Relationships to Disclose